A detailed history of Toth Financial Advisory Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Toth Financial Advisory Corp holds 11 shares of NVO stock, worth $1,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Holding current value
$1,527
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $1,123 - $1,495
11 New
11 $1,000
Q3 2020

Oct 16, 2020

SELL
$63.69 - $70.22 $254,760 - $280,880
-4,000 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$58.54 - $67.94 $234,160 - $271,760
4,000 New
4,000 $261,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $313B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.